Dr. Noordsy KEY RESEARCH

Douglas Noordsy

Douglas Noordsy, MD

Professor of Psychiatry
Geisel School of Medicine at Dartmouth

(Sep, 2021) The Lifestyle Psychiatry project of the WPA Section on Medicine, Psychiatry and Primary Care. Word Psychiatry: Official Journal of the World Psychiatric Association.
(Feb, 2021) Advancing Medical Education Through Innovations in Teaching During the COVID-19 Pandemic. The Primary Care Companion for CNS Disorders.
(2019) Lifestyle Psychiatry. American Psychiatric Association for Publishing.

(Jun, 2018) Clozapine Titration for People in Early Psychosis: A Chart Review and Treatment Guideline. Journal of Clinical Psychopharmacology.
(Sep, 2017) Risperidone versus olanzapine among patients with schizophrenia participating in supported employment: Eighteen-month outcomes. Journal of Psychiatric Research.
(May, 2016) Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders. Current Addiction Reports.
(Oct, 2015) Long-acting injectable vs oral risperidone for schizophrenia and co-occurring alcohol use disorder: a randomized trial. Journal of Clinical Psychiatry.
(Jan, 2015) Low-Dose Quetiapine Induced or Worsened Mania in the Context of Possible Undertreatment. Journal of the American Board of Family Medicine.
(Oct, 2011) Neuroleptic Malignant Syndrome During Multiple Antipsychotic Therapy. Community Mental Health Journal.
(April, 2011) A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia. Journal of Dual Diagnosis.
(May, 2009) Treatment of catatonic schizophrenia with lorazepam and aripiprazole. Schizophrenia Research.
(April, 2001) Six-Month Outcomes for Patients Who Switched to Olanzapine Treatment. Psychiatric Services.

(April, 2020) Lived experience perspectives on reducing the duration of untreated psychosis: the impact of stigma on accessing treatment. Psychosis.
(April, 2019) Validation of the NDSE, A New Self Report Scale for People with Psychosis. The Journal of Psychoses and Related Disorders.
(2019) Intervening Early in Psychosis: A Team Approach. American Psychiatric Association for Publishing.
(Jun, 2018) Impact of age of onset of psychosis and engagement in higher education on duration of untreated psychosis. Journal of Mental Health.
(Oct, 2018) Consumer and Family Perspectives on Reducing the Duration of Untreated Psychosis. Early Intervention in Psychiatry.
(Mar, 2018) Therapeutic Potential of Physical Exercise in Early Psychosis. The American Journal of Psychiatry.

(Sep, 2021) Increased activation product of complement 4 protein in plasma of individuals with schizophrenia. Translational Psychiatry.
(April, 2018) Factors motivating spontaneous exercise in individuals with schizophrenia-spectrum disorders. Schizophrenia Research.
(Nov, 2018) Why Do People With Schizophrenia Exercise? A Mixed Methods Analysis Among Community Dwelling Regular Exercisers. Frontiers in Psychiatry.
(Dec, 2017) Genetic Correlation Profile of Schizophrenia Mirrors Epidemiological Results and Suggests Link Between Polygenic and Rare Variant (22q11.2) Cases of Schizophrenia. The Journal of Psychoses and Related Disorders.
(March, 2017) Genetic Correlation Analysis of Schizophrenia Mirrors Known Epidemiological Relationships and Suggests Novel Associations. Schizophrenia Bulletin.
(Nov, 2016) An RCT Evaluating the Effects of Skills Training and Medication Type on Work Outcomes Among Patients With Schizophrenia. Psychiatric Services.
(Jul, 2016) Ethical Issues in the Care of People With Schizophrenia. Focus: The Journal of Lifelong Learning in Psychiatry.